31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          The incidence of colorectal cancer (CRC) declines among subjects aged 50 years and above. An opposite trend appears among younger adults. In Europe, data on CRC incidence among younger adults are lacking. We therefore aimed to analyse European trends in CRC incidence and mortality in subjects younger than 50 years.

          Design

          Data on age-related CRC incidence and mortality between 1990 and 2016 were retrieved from national and regional cancer registries. Trends were analysed by Joinpoint regression and expressed as annual percent change.

          Results

          We retrieved data on 143.7 million people aged 20–49 years from 20 European countries. Of them, 187 918 (0.13%) were diagnosed with CRC. On average, CRC incidence increased with 7.9% per year among subjects aged 20–29 years from 2004 to 2016. The increase in the age group of 30–39 years was 4.9% per year from 2005 to 2016, the increase in the age group of 40–49 years was 1.6% per year from 2004 to 2016. This increase started earliest in subjects aged 20–29 years, and 10–20 years later in those aged 30–39 and 40–49 years. This is consistent with an age-cohort phenomenon. Although in most European countries the CRC incidence had risen, some heterogeneity was found between countries. CRC mortality did not significantly change among the youngest adults, but decreased with 1.1%per year between 1990 and 2016 and 2.4% per year between 1990 and 2009 among those aged 30–39 years and 40–49 years, respectively.

          Conclusion

          CRC incidence rises among young adults in Europe. The cause for this trend needs to be elucidated. Clinicians should be aware of this trend. If the trend continues, screening guidelines may need to be reconsidered.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: found
          • Article: not found

          Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society

          In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence. Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early detection of CRC. Results from modeling analyses identified efficient and model-recommendable strategies that started screening at age 45 years. The ACS Guideline Development Group applied the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria in developing and rating the recommendations. The ACS recommends that adults aged 45 years and older with an average risk of CRC undergo regular screening with either a high-sensitivity stool-based test or a structural (visual) examination, depending on patient preference and test availability. As a part of the screening process, all positive results on noncolonoscopy screening tests should be followed up with timely colonoscopy. The recommendation to begin screening at age 45 years is a qualified recommendation. The recommendation for regular screening in adults aged 50 years and older is a strong recommendation. The ACS recommends (qualified recommendations) that: 1) average-risk adults in good health with a life expectancy of more than 10 years continue CRC screening through the age of 75 years; 2) clinicians individualize CRC screening decisions for individuals aged 76 through 85 years based on patient preferences, life expectancy, health status, and prior screening history; and 3) clinicians discourage individuals older than 85 years from continuing CRC screening. The options for CRC screening are: fecal immunochemical test annually; high-sensitivity, guaiac-based fecal occult blood test annually; multitarget stool DNA test every 3 years; colonoscopy every 10 years; computed tomography colonography every 5 years; and flexible sigmoidoscopy every 5 years. CA Cancer J Clin 2018;68:250-281. © 2018 American Cancer Society.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Colorectal Cancer Incidence Patterns in the United States, 1974-2013.

            Colorectal cancer (CRC) incidence in the United States is declining rapidly overall but, curiously, is increasing among young adults. Age-specific and birth cohort patterns can provide etiologic clues, but have not been recently examined.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies.

              Whereas obesity has been associated with an increased risk of colon cancer in men, a weak or no association has been observed in women. Results for rectal cancer have also been inconsistent. The objective was to perform a meta-analysis to summarize the available evidence from prospective studies on the associations of overall and abdominal obesity with the risk of colon and rectal cancer. We searched MEDLINE (1966-April 2007) and the references of the retrieved articles. Study-specific relative risks (RRs) were pooled by using a random-effects model. Thirty prospective studies were included in the meta-analysis of body mass index (BMI; in kg/m(2)). Overall, a 5-unit increase in BMI was related to an increased risk of colon cancer in both men (RR: 1.30; 95% CI: 1.25, 1.35) and women (RR: 1.12; 95% CI: 1.07, 1.18), but the association was stronger in men (P < 0.001). BMI was positively associated with rectal cancer in men (RR: 1.12; 95% CI: 1.09, 1.16) but not in women (RR: 1.03; 95% CI: 0.99, 1.08). The difference in RRs between cancer sites was statistically significant (P < 0.001 in men and P = 0.04 in women). Colon cancer risk increased with increasing waist circumference (per 10-cm increase) in both men (RR: 1.33; 95% CI: 1.19, 1.49) and women (RR: 1.16; 95% CI: 1.09, 1.23) and with increasing waist-hip ratio (per 0.1-unit increase) in both men (RR: 1.43; 95% CI: 1.19, 1.71) and women (RR: 1.20; 95% CI: 1.08, 1.33). The association between obesity and colon and rectal cancer risk varies by sex and cancer site.
                Bookmark

                Author and article information

                Journal
                Gut
                Gut
                gutjnl
                gut
                Gut
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0017-5749
                1468-3288
                October 2019
                16 May 2019
                : 68
                : 10
                : 1820-1826
                Affiliations
                [1 ] departmentGastroenterology and Hepatology , Erasmus MC University Medical Center , Rotterdam, The Netherlands
                [2 ] departmentPublic Health , Erasmus MC University Medical Center , Rotterdam, The Netherlands
                [3 ] departmentCentre d’investigations Clinique INSERM 1432 , CHU Dijon-Bourgogne , Dijon, France
                [4 ] departmentGastroenterology , Portuguese Oncology Institute of Porto , Porto, Portugal
                [5 ] departmentCINTESIS , Porto Faculty of Medicine, University of Porto , Porto, Portugal
                [6 ] departmentNorth Region Cancer Registry (RORENO), Department of Epidemiology , Portuguese Oncology Institute of Porto , Porto, Portugal
                [7 ] departmentEpidemiology and Cancer Registry , Institute of Oncology , Ljubljana, Slovenia
                [8 ] departmentGastroenterology Department , Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona , Barcelona, Spain
                [9 ] departmentCatalan Cancer Plan , Catalan Institute of Oncology, L’Hospitalet del Llobregat , Barcelona, Spain
                [10 ] departmentCancer Prevention , The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology , Warsaw, Poland
                [11 ] departmentGastroenterology, Hepatology and Clinical Oncology , Medical Centre for Postgraduate Education , Warsaw, Poland
                [12 ] departmentDepartment of Health Management and Health Economics , University of Oslo , Oslo, Norway
                [13 ] departmentInternal Medicine , 1st Faculty of Medicine, Charles University, Military University Hospital , Prague, Czech Republic
                [14 ] departmentFaculty of Medicine, Masaryk University , Institute of Biostatistics and Analyses , Brno, Czech Republic
                [15 ] Institute of Health Information and Statistics of the Czech Republic , Prague, Czech Republic
                [16 ] departmentInstitute of Clinical and Preventive Medicine & Faculty of Medicine , University of Latvia , Riga, Latvia
                Author notes
                [Correspondence to ] Dr Manon CW Spaander, Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam 3015CE, The Netherlands ; v.spaander@ 123456erasmusmc.nl
                Author information
                http://orcid.org/0000-0002-9103-9757
                Article
                gutjnl-2018-317592
                10.1136/gutjnl-2018-317592
                6839794
                31097539
                08489e51-2cee-44d8-9047-46c3814454e9
                © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

                History
                : 13 September 2018
                : 29 March 2019
                : 31 March 2019
                Categories
                Colon
                1506
                2312
                Original article
                Custom metadata
                unlocked

                Gastroenterology & Hepatology
                colorectal cancer,epidemiology,screening
                Gastroenterology & Hepatology
                colorectal cancer, epidemiology, screening

                Comments

                Comment on this article